Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-17 Dubovsky Filip President, R&D Exercise or conversion +1,404 $6.97 $10K 68,017
2024-06-17 Dubovsky Filip President, R&D Exercise or conversion +12,500 $6.09 $76K 80,517
2024-06-17 Dubovsky Filip President, R&D Sale −12,500 $14.46 $181K 68,017
2024-06-17 Dubovsky Filip President, R&D Sale −1,404 $14.54 $20K 66,613
2024-06-17 Dubovsky Filip President, R&D Exercise or conversion · Stock Option (Right to Buy) −1,404 $6.97 $10K 46,324
2024-06-17 Dubovsky Filip President, R&D Exercise or conversion · Stock Option (Right to Buy) −12,500 $6.09 $76K 37,500
2024-05-14 Dubovsky Filip President, R&D Exercise or conversion +19,652 $6.97 $137K 86,265
2024-05-14 Dubovsky Filip President, R&D Sale −47,312 $13.90 $658K 38,953
2024-05-14 Dubovsky Filip President, R&D Exercise or conversion · Stock Option (Right to Buy) −19,652 47,728
2024-03-10 Dubovsky Filip President, R&D Exercise or conversion +5,376 69,210
2024-03-10 Dubovsky Filip President, R&D Shares withheld for taxes −2,597 $5.45 $14K 66,613
2024-03-10 Dubovsky Filip President, R&D Exercise or conversion · Restricted Stock Units −5,376 5,376
2024-03-07 Dubovsky Filip President, R&D Exercise or conversion +19,444 73,226
2024-03-07 Dubovsky Filip President, R&D Shares withheld for taxes −9,392 $5.61 $53K 63,834
2024-03-07 Dubovsky Filip President, R&D Exercise or conversion · Restricted Stock Units −19,444 0
2024-03-01 Dubovsky Filip President, R&D Grant or award · Restricted Stock Units +144,000 144,000
2023-12-14 Dubovsky Filip President, R&D Exercise or conversion +2,833 $5.69 $16K 55,150
2023-12-14 Dubovsky Filip President, R&D Shares withheld for taxes −1,368 $5.69 $8K 53,782
2023-12-14 Dubovsky Filip President, R&D Exercise or conversion · Restricted Stock Units −2,833 0
2023-11-05 Dubovsky Filip President, R&D Exercise or conversion +1,400 $7.06 $10K 52,994

Page 1 of 2 · 28 trades